The InteractiveFly: Drosophila as a Model for Human Diseases

Spastic paraplegia
Reviews | PubMed | Wikipedia | More in IF

Drosophila genes associated with Spastic paraplegia

Related terms

Neuromuscular junction
Overview of the disease

Hereditary spastic paraplegias (HSPs) are a group of neurodegenerative disorders marked by lower-limb spasticity (stiffness) and weakness, leading to progressive difficulty walking. Supportive treatments exist, but are of mixed efficacy and do not restore mobility. The most common form, pure autosomal dominant HSP (AD-HSP), accounts for 70–80% of HSP-afflicted families. AD-HSP pathology is characterized primarily by degeneration of the longest descending axons of the central nervous system (CNS). These originate from the upper motor neurons in the cortex and terminate in the lumbar spine, innervating the α1 motor neurons that control leg movement. In regards to providing a model for AD-HSP, Drosophila Spastin, like its vertebrate orthologs, severs purified microtubules and those in Drosophila S2 cells. Knocking down fly Spastin using a RNA-interference (RNAi) transgene or deletion of the endogenous gene both cause synaptic defects at the Drosophila larval neuromuscular junction (NMJ), supporting a role for spastin in regulating synaptic morphology and function. Orthologs of several other HSP causative genes studied in Drosophila also exhibit progressive neurodegeneration, supporting the relevance of flies in providing insights into mechanisms underlying this disease (Baxter, 2014 and references therein).

Go to top

Relevant studies of Spastic paraplegia

Julien, C., Lissouba, A., Madabattula, S., Fardghassemi, Y., Rosenfelt, C., Androschuk, A., Strautman, J., Wong, C., Bysice, A., O'Sullivan, J., Rouleau, G.A., Drapeau, P., Parker, J.A. and Bolduc, F.V. (2016). Conserved pharmacological rescue of hereditary spastic paraplegia-related phenotypes across model organisms. Hum Mol Genet [Epub ahead of print]. PubMed ID: 26744324

Hereditary spastic paraplegias (HSPs) are a group of neurodegenerative diseases causing progressive gait dysfunction. Over 50 genes have now been associated with HSP. Despite the recent explosion in genetic knowledge, HSP remains without pharmacological treatment. Loss-of-function mutation of the SPAST gene, also known as SPG4, is the most common cause of HSP in patients. SPAST is conserved across animal species and regulates microtubule dynamics. Recent studies have shown that it also modulates endoplasmic reticulum (ER) stress. Here, utilizing null SPAST homologues in C. elegans, Drosophila and zebrafish, this study tested FDA-approved compounds known to modulate ER stress in order to ameliorate locomotor phenotypes associated with HSP. It was found that locomotor defects found in all of the spastin models could be partially rescued by phenazine, methylene blue, N-acetyl-cysteine, guanabenz and salubrinal. In addition, it was shown that established biomarkers of ER stress levels correlate with improved locomotor activity upon treatment across model organisms. These results provide insights into biomarkers and novel therapeutic avenues for HSP (Julien, 2016).


  • Methylene blue, phenazine, and N-Acetyl-L-cysteine rescue the negative geotaxis defects caused by spastin loss of function in Drosophila.

Go to top

Xu, S., Stern, M. and McNew, J. A. (2016). Beneficial effects of rapamycin in a Drosophila model for hereditary spastic paraplegia. J Cell Sci [Epub ahead of print]. PubMed ID: 27909242


The locomotor deficits in the hereditary spastic paraplegias (HSPs) reflect degeneration of upper motor neurons, but the mechanisms underlying this neurodegeneration are unknown. This study established a Drosophila model for the HSP atlastin (atl), which encodes an ER fusion protein. Neuronal atl loss causes degeneration of specific thoracic muscles that is preceded by other pathologies including accumulation of aggregates containing poly-ubiquitin (poly-UB), increased generation of reactive oxygen species, and activation of the JNK/Foxo stress response pathway. Inhibiting the Tor kinase, either genetically or by administering rapamycin, at least partially reversed many of these pathologies. atl loss from muscle also triggers muscle degeneration and rapamycin-sensitive locomotor deficits and poly-UB aggregate accumulation. These results indicate that atl loss triggers muscle degeneration both cell autonomously and nonautonomously (Xu, 2016).

Go to top

Galikova, M., Klepsatel, P., Munch, J. and Kuhnlein, R. P. (2017). Spastic paraplegia-linked phospholipase PAPLA1 is necessary for development, reproduction, and energy metabolism in Drosophila. Sci Rep 7: 46516. PubMed ID: 28422159


The human PAPLA1 phospholipase family is associated with hereditary spastic paraplegia (HSP), a neurodegenerative syndrome characterized by progressive spasticity and weakness of the lower limbs. Taking advantage of a new Drosophila PAPLA1 mutant, this study describes novel functions of this phospholipase family in fly development, reproduction, and energy metabolism. Loss of Drosophila PAPLA1 reduces egg hatchability, pre-adult viability, developmental speed, and impairs reproductive functions of both males and females. In addition, this work describes novel metabolic roles of PAPLA1, manifested as decreased food intake, lower energy expenditure, and reduced ATP levels of the mutants. Moreover, PAPLA1 has an important role in the glycogen metabolism, being required for expression of several regulators of carbohydrate metabolism and for glycogen storage. In contrast, global loss of PAPLA1 does not affect fat reserves in adult flies. Interestingly, several of the PAPLA1 phenotypes in fly are reminiscent of symptoms described in some HSP patients, suggesting evolutionary conserved functions of PAPLA1 family in the affected processes. Altogether, this work reveals novel physiological functions of PAPLA1, which are likely evolutionary conserved from flies to humans (Galikova, 2017).

Go to top

Yalcin, B., Zhao, L., Stofanko, M., O'Sullivan, N. C., Kang, Z. H., Roost, A., Thomas, M. R., Zaessinger, S., Blard, O., Patto, A. L., Sohail, A., Baena, V., Terasaki, M. and O'Kane, C. J.(2017). Modeling of axonal endoplasmic reticulum network by spastic paraplegia proteins. Elife 6. PubMed ID: 28742022


Axons contain a smooth tubular endoplasmic reticulum (ER) network that is thought to be continuous with ER throughout the neuron; the mechanisms that form this axonal network are unknown. Mutations affecting reticulon or REEP (Drosophila Reep1) proteins, with intramembrane hairpin domains that model ER membranes, cause an axon degenerative disease, hereditary spastic paraplegia (HSP). This study shows that Drosophila axons have a dynamic axonal ER network, which these proteins help to model. Loss of HSP hairpin proteins causes ER sheet expansion, partial loss of ER from distal motor axons, and occasional discontinuities in axonal ER. Ultrastructural analysis reveals an extensive ER network in axons, which shows larger and fewer tubules in larvae that lack reticulon and REEP proteins, consistent with loss of membrane curvature. Therefore HSP hairpin-containing proteins are required for shaping and continuity of axonal ER, thus suggesting roles for ER modeling in axon maintenance and function (Yalcin, 2017).

Go to top

Du, F., Ozdowski, E.F., Kotowski, I.K., Marchuk, D.A. and Sherwood, N.T. (2010). Functional conservation of human Spastin in a Drosophila model of autosomal dominant-hereditary spastic paraplegia. Hum Mol Genet 19: 1883-1896. PubMed ID: 20154342

Mutations in spastin are the most frequent cause of the neurodegenerative disease autosomal dominant-hereditary spastic paraplegia (AD-HSP). Drosophila melanogaster lacking spastin exhibit striking behavioral similarities to human patients suffering from AD-HSP, suggesting conservation of Spastin function between the species. Consistent with this, this study shows that exogenous expression of wild-type Drosophila or human spastin rescues behavioral and cellular defects in spastin null flies equivalently. This enabled generation of genetically representative models of AD-HSP, which arises from dominant mutations in spastin rather than a complete loss of the gene. Flies co-expressing one copy of wild-type human spastin and one encoding the K388R catalytic domain mutation in the fly spastin null background, exhibit aberrant distal synapse morphology and microtubule distribution, similar to but less severe than spastin nulls. R388 or a separate nonsense mutation act dominantly and are furthermore sufficient to confer partial rescue, supporting in vitro evidence for additional, non-catalytic Spastin functions. Using this model, the observation from human pedigrees that S44L and P45Q are trans-acting modifiers of mutations affecting the Spastin catalytic domain, were tested. As in humans, both L44 and Q45 are largely silent when heterozygous, but exacerbate mutant phenotypes when expressed in trans with R388. These transgenic ‘AD-HSP’ flies therefore provide a powerful and tractable model to enhance understanding of the cellular and behavioral consequences of human spastin mutations and test hypotheses directly relevant to the human disease (Du, 2010).


  • Generation and expression of Drosophila and human spastin in vivo.
  • Fly and human spastin transgenes have similar subcellular distributions.
  • Human and Drosophila Spastin are functionally conserved.
  • Generation and characterization of AD-HSP flies.
  • The amino-terminus S44L mutation in Spastin exacerbates R388 catalytic domain mutant phenotypes but is itself only mildly deleterious.

Towards understanding the mechanisms by which spastin mutations lead to neuronal dysfunction in AD-HSP and uncovering possible therapeutic approaches for the disease, this study generated a model in which flies deleted for endogenous spastin instead express the wild-type or mutated human ortholog in allelic combinations that mimic the human disease genotype. Using these animals it was shown that human spastin is functionally equivalent to that of the fly, rescuing the null phenotype as effectively as the fly gene when expressed at low levels in neurons. At the cellular level, rather than exhibiting small, clustered synaptic boutons containing little or no MAP1B-positive microtubules, NMJs in animals expressing human spastin in place of the fly's exhibit large, linearly arrayed boutons containing distinct microtubule loop structures, like those seen in wild-type controls or in spastin null flies expressing an exogenous wild-type Drosophila spastin transgene. Behaviorally, eclosion rates and adult mobility are also visibly and equivalently improved by the expression of human or fly spastin (Du, 2010).

Consistent with their functional conservation, both the fly and human spastin proteins are diffusely distributed in the cytoplasm and can permeate throughout long neuronal processes. Overexpression does reveal some differences between the two proteins, however. Human Spastin forms more aggregates than does fly Spastin; this is observed independent of the transgene insertion, and whether a genomic or cDNA fly transgene is used. Additionally, two copies of the fly wild-type transgene become deleterious to rescue, although no significant differences are observed between one and two copies of the human transgene. Processing of these two proteins is therefore not identical in this overexpression context, although their ability to substitute for the loss of endogenous spastin is indistinguishable (Du, 2010).

Although differences in transgene expression levels are one caveat of the GAL4-UAS expression system, analysis of the various insertion lines used in these experiments reveals that the observed mutant phenotypes are relatively insensitive to expression levels, correlating instead with the different recombinant genotypes. Pathogenic AD-HSP genotypes resemble spastin loss of function phenotypes at behavioral, cellular and subcellular levels. The ability of the human pathogenic mutations to mimic the cellular and subcellular spastin null phenotypes is even more remarkable given that this phenotype of numerous small, clustered boutons devoid of microtubules has not been observed in other mutants affecting the larval NMJ, including mutations in other closely related microtubule severing proteins. This underscores the specificity of these phenotypes and their direct relation to Spastin function (Du, 2010).

Further data support the validity of these flies as a model for the human disease, and furthermore as the only model demonstrating robust behavioral phenotypes in the heterozygous mutant condition that typifies most AD-HSP patients. Using this model, human pedigree analyses, correlating disease augmentation with trans-heterozygous expression of L44 or Q45 and mutations interfering with Spastin's catalytic domain, were confirmed, substantiating the significance of this amino-terminal region in normal Spastin function. Although humans heterozygous for the S44L mutation are typically asymptomatic, the mutation may have some effect on protein function at the cellular and subcellular levels. Consistent with this observation, abnormal electromyogram measurements have been found in L44 heterozygous individuals despite their outward lack of disease symptoms (Du, 2010).

Several hypotheses have been proposed for the mechanism underlying exacerbated disease severity in the compound heterozygous condition. Modifier effects could occur at the level of the spastin protein; for instance, S44/P45 may be a phosphorylation target important in the regulation of Spastin function. S44 is also predicted to comprise part of a PEST sequence, such that mutations in it would interfere with degradation of full-length (but not truncated) Spastin isoforms. Alternatively, the base pair mutations underlying these amino acid substitutions fall within a predicted cryptic promoter in the first exon, and could affect its activity and inhibit the transcription of the shorter spastin isoform. These data argue against a transcriptional mechanism, given that transgene expression in the AD-HSP model flies is under the control of an exogenous promoter. However, the precise mechanism of the exacerbating effect remains to be resolved, and can be directly tested in this model (Du, 2010).

A growing list of Drosophila models of HSP is contributing key insights to the function of the human spastic gait (SPG) genes: in addition to SPG4/spastin, these include SPG3A/atlastin, a novel GTPase shown in flies to be required for ER morphogenesis, SPG6/NIPA1, elucidated as a regulator of BMP signaling through studies of its Drosophila ortholog spicthyn and SPG39/NTE, Drosophila Swiss-cheese, mutations in which disrupt the kinase activity and localization of PKA-C3 and cause progressive neurodegeneration (Du, 2010).

Go to top

Baxter, S.L., Allard, D.E., Crowl, C. and Sherwood, N.T. (2014). Cold temperature improves mobility and survival in Drosophila models of autosomal-dominant hereditary spastic paraplegia (AD-HSP). Dis Model Mech 7: 1005-1012. PubMed ID: 24906373

Autosomal-dominant hereditary spastic paraplegia (AD-HSP) is a crippling neurodegenerative disease for which effective treatment or cure remains unknown. Victims experience progressive mobility loss due to degeneration of the longest axons in the spinal cord. Over half of AD-HSP cases arise from loss-of-function mutations in spastin, which encodes a microtubule-severing AAA ATPase. In Drosophila models of AD-HSP, larvae lacking Spastin exhibit abnormal motor neuron morphology and function, and most die as pupae. Adult survivors display impaired mobility, reminiscent of the human disease. This study shows that rearing pupae or adults at reduced temperature (18°C), compared with the standard temperature of 24°C, improves the survival and mobility of adult spastin mutants but leaves wild-type flies unaffected. Flies expressing human spastin with pathogenic mutations are similarly rescued. Additionally, larval cooling partially rescues the larval synaptic phenotype. Cooling thus alleviates known spastin phenotypes for each developmental stage at which it is administered and, notably, is effective even in mature adults. Further, cold treatment rescues larval synaptic defects in flies with mutations in Flower (a protein with no known relation to Spastin) and mobility defects in flies lacking Kat60-L1, another microtubule-severing protein enriched in the CNS. Together, these data support the hypothesis that the beneficial effects of cold extend beyond specific alleviation of Spastin dysfunction, to at least a subset of cellular and behavioral neuronal defects. Mild hypothermia, a common neuroprotective technique in clinical treatment of acute anoxia, might thus hold additional promise as a therapeutic approach for AD-HSP and, potentially, for other neurodegenerative diseases (Baxter, 2014).


  • Pupal stage cold treatment improves spastin mutant eclosion.
  • Both pupal and adult cold treatment improve adult mobility.
  • Pupal stage cold treatment extends lifespan.
  • Pupal stage cold treatment improves eclosion and mobility of AD-HSP genotype flies.
  • Cooling rescues synapse morphology defects in spastin larvae.
  • Mutants in flower and kat-60L1 are also rescued by cold treatment.

This study demonstrates that cold temperature alleviates reduced mobility and survival caused by loss of Spastin function in Drosophila. This is the case for flies lacking endogenous spastin, as well as those expressing pathogenic human Spastin. Cold treatment during the pupal stage of development is sufficient to enhance the eclosion rate, climbing ability and lifespan of spastin mutant adults. Furthermore, cold administered only after pupal development, to fully developed adults, also improves mutant mobility. The timing of these two effective periods is consistent with the idea that cold alleviates spastin mutant phenotypes by acting on the developing adult nervous system during pupal metamorphosis, but is also potent after the nervous system has matured. This is extremely promising from a clinical viewpoint, suggesting that the therapeutic window in AD-HSP includes both developing and mature nervous systems (Baxter, 2014).

Although wild-type levels of mobility and survival were not often achieved, the temperature shift to 18°C confers considerable improvement. Some cold-treated flies are able to jump and even fly briefly, behaviors not observed in untreated mutants. Cooling can match or exceed the efficacy of rescue by the microtubule destabilizing drug vinblastine, which has been proposed as a therapeutic approach for AD-HSP. It has been shown that vinblastine doubles the ~12% eclosion rate of spastin5.75 null mutants; however, this study found the drug to be ineffective for null and HL44,HR388 eclosion, but improved eclosion by 65% for HWT,HR388, which is a more common, representative AD-HSP genotype associated with milder pathogenesis. In comparison, pupal cooling of spastin5.75 null mutants increases eclosion by 70% (Baxter, 2014).

Importantly, cooling during the pupal and adult stages does not affect eclosion or motor behavior in wild-type flies. This suggests that cooling not only compensates for defects in neuronal function caused by lack of Spastin (or other mutations), but is also innocuous to properly functioning neurons. Although cooling administered at the larval stage is ultimately deleterious to both control and spastin mutant adults, mutant larval synapses are effectively restored to wild-type morphologies. This suggests that cold is beneficial for some spastin-mediated defects at this stage, but also has nonspecific, toxic effects on a cell population required later, in adults (Baxter, 2014).

What is the mechanism(s) underlying the rescuing effect of cold? The demonstration that cold alleviates not just spastin mutant phenotypes, but also mutant phenotypes in fwe and kat-60L1, indicates that that rescuing effects of cold on nervous system function might be quite broad. All three genes are important in synapse formation, although kat-60L1 has been shown to act post-rather than pre-synaptically at larval and pupal stages. Reduced temperature could thus be generally beneficial to synaptic dysfunction, perhaps by reducing activity or metabolic load. Alternatively, fwe, spastin and kat-60L1 might share a common pathway component(s), as yet undiscovered, that is directly affected by cold. For example, cold itself is well known to destabilize microtubules, particularly at temperatures below 20°C, and is often used in experiments to depolymerize microtubules. Cold could thus substitute directly for the microtubule-severing function of Spastin by promoting microtubule destabilization. Cold-mediated rescue of Kat-60L1 mutants support this idea; however, obvious differences in stable microtubule distribution at cold-treated spastin5.75 synapses or in Drosophila S2R+ cells were not observed; fwe mutants, which have not been implicated in microtubule dysregulation, were also rescued by cooling (Baxter, 2014).

In humans, cooling has been shown to be generally neuroprotective, and mild or moderate therapeutic hypothermia (e.g. 33–35°C) has long had clinical applications, including reducing neurological injury in patients following cardiac arrest, traumatic brain injury, epilepsy and stroke. Furthermore, exposure to even near-freezing temperatures results in minimal neuropathology in rat and cat neocortex and hippocampus. Although commonly administered in situations involving acute brain injury, the mechanism by which cooling confers neuroprotection or therapeutic improvement is unknown, multifactorial and context-dependent (Baxter, 2014).

It will be important to characterize the in vivo effects of cold in mouse models of AD-HSP. The specificity of the effect of cold on mutant and not wild-type animals, together with the spatially localized neurodegeneration in AD-HSP, suggest that moderate hypothermia could be applied in a highly targeted manner in this disease context, with minimal negative effects. Future studies should furthermore elucidate the underlying cellular mechanisms and potentially broader applications of cold in alleviating neuronal dysfunction in neurodegeneration. Because Drosophila are ectothermic, with body temperatures that vary with their environment, they provide a straightforward system in which the cell biological effects of temperature change can be studied in vivo (Baxter, 2014).

Go to top

Sujkowski, A., Rainier, S., Fink, J.K. and Wessells, R.J. (2015). Delayed induction of human NTE (PNPLA6) rescues neurodegeneration and mobility defects of Drosophila swiss cheese (sws) mutants. PLoS One 10: e0145356. PubMed ID: 26671664

Human PNPLA6 gene encodes Neuropathy Target Esterase protein (NTE). PNPLA6 gene mutations cause hereditary spastic paraplegia (SPG39 HSP), Gordon-Holmes syndrome, Boucher-Neuhäuser syndromes, Laurence-Moon syndrome, and Oliver-McFarlane syndrome. Mutations in the Drosophila NTE homolog swiss cheese (sws) cause early-onset, progressive behavioral defects and neurodegeneration characterized by vacuole formation. This study investigates sws5 flies and shows that this allele causes progressive vacuolar formation in the brain and progressive deterioration of negative geotaxis speed and endurance. It was demonstrated that inducible, neuron-specific expression of full-length human wildtype NTE reduces vacuole formation and substantially rescues mobility. Indeed, neuron-specific expression of wildtype human NTE is capable of rescuing mobility defects after 10 days of adult life at 29°C, when significant degeneration has already occurred, and significantly extends longevity of mutants at 25°C. These results raise the exciting possibility that late induction of NTE function may reduce or ameliorate neurodegeneration in humans even after symptoms begin. In addition, these results highlight the utility of negative geotaxis endurance as a new assay for longitudinal tracking of degenerative phenotypes in Drosophila (Sujkowski, 2015).


  • hNTE rescues sws5 esterase activity.
  • hNTE improves sws5 negative geotaxis.
  • hNTE improves sws5 endurance.
  • Vacuolization of sws5 brains is reduced by hNTE.
  • Delayed hNTE expression improves sws5 motor function and histopathology.
  • hNTE improves sws5 survival.

Neurodegenerative diseases are almost always diagnosed well after onset of symptoms. Reducing impairment after the development of disease is thus an important therapeutic goal. Significant neuronal cell death and vacuolization in sws5 mutants is observed within the first ten days of life, while mobility impairments are apparent by day 3 of age (Sujkowski, 2015).

Whereas previous studies also observe reduced vacuole formation in sws1 flies overexpressing Drosophila, mouse, or human PLNPA6, this study correlates reduced vacuole formation with longitudinal measures of mobility performance using a recently developed protocol for measuring Drosophila endurance. Measuring endurance with an automated system for inducing negative geotaxis behavior offers a non-invasive assessment of both coordination and strength, suitable for longitudinal assessment of performance decline. This system effectively measures performance decline as a result of either muscle-specific interventions. This system can be useful for future assessments of degenerative disease models or as an assessment of functional aging (Sujkowski, 2015).

Because hNTE expression is not induced in mutants until after development is complete, some developmental mobility defects could persist in adult hNTE rescue flies. However, hNTE rescue flies exhibit consistently faster climbing speed and higher endurance in comparison to both sws5 mutants and transgenic controls. Furthermore, induction of rescue even after substantial decline has taken place in adults can not only slow decline, but actually reverse the decline in endurance of a longitudinally measured cohort (Sujkowski, 2015).

Taken together, these observations imply that protection of mobility may not absolutely require reversal of vacuole formation. Blocking the formation of additional vacuoles, or blocking the expansion of existing vacuoles may be sufficient to allow some degree of functional recovery. These results support the idea that induction of NTE activity may be therapeutically valuable even after substantial degeneration has occurred. Extending these studies to vertebrate models of NTE mutation will be critical (Sujkowski, 2015).

Go to top

Wang, X., Shaw, W.R., Tsang, H.T., Reid, E. and O'Kane, C.J. (2007). Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules. Nat Neurosci 10: 177-185. PubMed ID: 17220882

To understand the functions of SPG6, mutated in the neurodegenerative disease hereditary spastic paraplegia, and of ichthyin, mutated in autosomal recessive congenital ichthyosis, this study focused on their Drosophila ortholog, spichthyin (Spict). Spict is found on early endosomes. Loss of Spict leads to upregulation of BMP signaling and expansion of the neuromuscular junction. BMP signaling is also necessary for a normal microtubule cytoskeleton and axonal transport; analysis of loss and gain-of-function phenotypes suggests that Spict antagonizes this function of BMP signaling. Spict interacts with BMP receptors and promotes their internalization from the plasma membrane, suggesting that it inhibits BMP signaling by regulating BMP receptor traffic. This is the first demonstration of a role for an SPG protein or ichthyin family member in a specific signaling pathway, and suggests disease mechanisms for hereditary spastic paraplegia that involve dependence of the microtubule cytoskeleton on BMP signaling (Wang, 2007).


  • Drosophila Spict is widely expressed and is localized on early endosomes.
  • Spict regulates synaptic growth at the NMJ.
  • BMP signaling is essential for the NMJ expansion of spictmut.
  • Spict and BMP signaling regulate microtubules.
  • Spict antagonizes BMP signaling by regulating BMP receptor trafficking.

The opposing effects of Spict and BMP signaling on NMJ and neuronal microtubules suggest that Spict is a novel antagonist of BMP signaling. BMP signaling acts both presynaptically and postsynaptically at the NMJ; rescue experiments show that Spict acts presynaptically to regulate NMJ expansion. Data suggest a direct effect of Spict on the presynaptic BMP signaling machinery. First, elevated levels of PMad and BMP receptors are seen at spictmut NMJs. Second, Spict can be co-immunoprecipitated with Wit. Third, Spict shows partial colocalization with the BMP receptors Tkv-HA or Wit at NMJ boutons. Fourth, Spict promotes relocalization of Wit from the surface of S2 cells to the Rab5 early endosomal compartment. Therefore, data suggest strongly that Spict antagonizes BMP signaling by regulating its receptor traffic. This is in contrast to Highwire - while synaptic overgrowth in highwire mutants can be suppressed by BMP signaling mutants, the highwire phenotype is more completely suppressed by loss of the Wallenda MAP kinase kinase kinase, and there is no apparent upregulation of PMad in highwire mutants (Wang, 2007).

The posterior crossveinless phenotype in some spictmut adult wings is also typical of reduced BMP signaling in pupal wing discs. At first sight a crossveinless phenotype is inconsistent with Spict being an antagonist of BMP signaling. However, lowered BMP signaling in the posterior crossvein primordium could be due not only to direct downregulation of signaling, but also to upregulation of receptors that reduces diffusion of BMP ligands. Any changes in the level of BMP signaling about the time when the posterior crossvein primordium develops were not detected, but this could be due to either the partial penetrance of the phenotype, or the robustness of the regulatory and feedback mechanisms that translate smooth gradients of BMP ligands into more sharply defined developmental features (Wang, 2007).

How might an endosomal protein regulate BMP signaling? Membrane trafficking from the plasma membrane to lysosomes regulates many signaling pathways including BMP/TGF-β. For example, mutations that impair endosome to lysosome traffic cause an increase in BMP signaling, in at least some cases accompanied by increased levels of Tkv. However, the predominant localization of Spict on early endosomes, and its ability to internalize Wit to this compartment suggest that Spict functions at some step of plasma membrane to endosome traffic. First, Rab5 compartments fail to accumulate at spictmut NMJs, rather than enlarge as in Hrs mutants. Second, Spict overexpression in S2 cells redistributes Wit mainly to early endosomes, rather than to late endosomes or lysosomes. Third, there is no obvious degradation of Wit in Spict-overexpressing cells that internalize Wit, suggesting that Spict does not directly target Wit for degradation, at least in S2 cells. While levels of BMP receptors are elevated locally in NMJ boutons that lack Spict, this could be either to altered trafficking or degradation, and BMP signaling in S2 cells can be affected by Spict, without detectable changes in levels of BMP receptors. Therefore, Spict might inhibit BMP signaling by internalizing vacant receptors and thus preventing them from responding to ligand; since clathrin RNAi treatment redistributes Spict to the plasma membrane, Spict probably appears at least transiently at the plasma membrane. However, more complex models are possible. For example, Spict might sequester BMP receptors in a compartment from which they cannot signal; Notch receptors apparently have to reach a specific endosomal compartment before they can signal (Wang, 2007).

By studying Spict, the study identifies a role for BMP signaling in maintenance of axonal microtubules. Notably, local loss of presynaptic microtubules has also been seen in loss of BMP signaling at the NMJ, and apical microtubule arrays are eliminated in tkv mutant clones in wing imaginal discs. Since BMP signaling promotes synaptic growth and synaptic strength at the NMJ, it would be logical for it also to stimulate the additional transport of materials and organelles that a larger more active synapse requires (Wang, 2007).

If human SPG6 alleles are dominant gain-of-function, then the HSP that they cause would resemble the situation of Spict overexpression in Drosophila, and axonal degeneration in HSP could then be caused by inhibition of BMP signaling, loss of axonal microtubules, and impaired axonal transport. Given the effect of BMP signaling on axonal microtubules, other HSP gene products apart from SPG6 may affect BMP signaling and thus maintenance of axonal microtubules (Wang, 2007).

Go to top

Papadopoulos, C., Orso, G., Mancuso, G., Herholz, M., Gumeni, S., Tadepalle, N., Jüngst, C., Tzschichholz, A., Schauss, A., Höning, S., Trifunovic, A., Daga, A. and Rugarli, E.I. (2015). Spastin binds to lipid droplets and affects lipid metabolism. PLoS Genet 11: e1005149. PubMed ID: 25875445

Mutations in SPAST, encoding spastin, are the most common cause of autosomal dominant hereditary spastic paraplegia (HSP). HSP is characterized by weakness and spasticity of the lower limbs, owing to progressive retrograde degeneration of the long corticospinal axons. Spastin is a conserved microtubule (MT)-severing protein, involved in processes requiring rearrangement of the cytoskeleton in concert to membrane remodeling, such as neurite branching, axonal growth, midbody abscission, and endosome tubulation. Two isoforms of spastin are synthesized from alternative initiation codons (M1 and M87). This study shows that spastin-M1 can sort from the endoplasmic reticulum (ER) to pre- and mature lipid droplets (LDs). A hydrophobic motif comprised of amino acids 57 through 86 of spastin is sufficient to direct a reporter protein to LDs, while mutation of arginine 65 to glycine abolishes LD targeting. Increased levels of spastin-M1 expression reduce the number but increase the size of LDs. Expression of a mutant unable to bind and sever MTs causes clustering of LDs. Consistent with these findings, ubiquitous overexpression of Dspastin in Drosophila leads to bigger and less numerous LDs in the fat bodies and increases triacylglycerol levels. In contrast, Dspastin overexpression increases LD number when expressed specifically in skeletal muscles or nerves. Downregulation of Dspastin and expression of a dominant-negative variant decreases LD number in Drosophila nerves, skeletal muscle and fat bodies, and reduces triacylglycerol levels in the larvae. Moreover, reduced amount of fat stores were found in intestinal cells of worms in which the spas-1 homologue is either depleted by RNA interference or deleted. Taken together, these data uncover an evolutionarily conserved role of spastin as a positive regulator of LD metabolism and open up the possibility that dysfunction of LDs in axons may contribute to the pathogenesis of HSP (Papadopoulos, 2015).

Go to top

Solowska, J.M., D'Rozario, M., Jean, D.C., Davidson, M.W., Marenda, D.R. and Baas, P.W. (2014). Pathogenic mutation of spastin has gain-of-function effects on microtubule dynamics. J Neurosci 34: 1856-1867. PubMed ID: 24478365

Mutations to the SPG4 gene encoding the microtubule-severing protein spastin are the most common cause of hereditary spastic paraplegia. Haploinsufficiency, the prevalent model for the disease, cannot readily explain many of its key aspects, such as its adult onset or its specificity for the corticospinal tracts. Treatment strategies based solely on haploinsufficiency are therefore likely to fail. Toward developing effective therapies, this study investigated potential gain-of-function effects of mutant spastins. The full-length human spastin isoform called M1 or a slightly shorter isoform called M87, both carrying the same pathogenic mutation C448Y, were expressed in three model systems: primary rat cortical neurons, fibroblasts, and transgenic Drosophila. Although both isoforms have ill effects on motor function in transgenic flies and decrease neurite outgrowth from primary cortical neurons, mutant M1 is notably more toxic than mutant M87. The observed phenotypes do not result from dominant-negative effects of mutated spastins. Studies in cultured cells reveal that microtubules can be heavily decorated by mutant M1 but not mutant M87. Microtubule-bound mutant M1 decreases microtubule dynamics, whereas unbound M1 or M87 mutant spastins increase microtubule dynamics. The alterations in microtubule dynamics observed in the presence of mutated spastins are not consistent with haploinsufficiency and are better explained by a gain-of-function mechanism. These results fortify a model wherein toxicity of mutant spastin proteins, especially mutant M1, contributes to axonal degeneration in the corticospinal tracts. Furthermore, these results provide details on the mechanism of the toxicity that may chart a course toward more effective treatment regimens (Solowska, 2014).


  • Human spastin isoforms M1 and M87 with pathogenic mutation C448Y interact differently with MTs and affect neurite outgrowth to different degrees.
  • Expression of mutated M1 C448Y in transgenic Drosophila affects motor function more than expression of M87 C448Y.
  • Spastin isoforms carrying C448Y mutation do not exhibit dominant-negative activity.
  • Mutated spastins affect MT dynamics in isoform-dependent fashion.

Go to top

Orso, G., Martinuzzi, A., Rossetto, M.G., Sartori, E., Feany, M. and Daga, A. (2005). Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine. J Clin Invest 115: 3026-3034. PubMed ID: 16276413

Hereditary spastic paraplegias (HSPs) are a group of neurodegenerative diseases characterized by progressive weakness and spasticity of the lower limbs. Dominant mutations in the human SPG4 gene, encoding spastin, are responsible for the most frequent form of HSP. Spastin is an ATPase that binds microtubules and localizes to the spindle pole and distal axon in mammalian cell lines. Furthermore, its Drosophila homolog, Drosophila spastin (Dspastin), regulates microtubule stability and synaptic function at the Drosophila larval neuromuscular junction. This study reports the generation of a spastin-linked HSP animal model and shows that in Drosophila, neural knockdown of Dspastin and, conversely, neural overexpression of Dspastin containing a conserved pathogenic mutation both recapitulate some phenotypic aspects of the human disease, including adult onset, locomotor impairment, and neurodegeneration. At the subcellular level, neuronal expression of both Dspastin RNA interference and mutant Dspastin cause an excessive stabilization of microtubules in the neuromuscular junction synapse. In addition, administration of the microtubule targeting drug vinblastine significantly attenuates these phenotypes in vivo. These findings demonstrate that loss of spastin function elicits HSP-like phenotypes in Drosophila, provide novel insights into the molecular mechanism of spastin mutations, and raise the possibility that therapy with Vinca alkaloids may be efficacious in spastin-associated HSP and other disorders related to microtubule dysfunction (Orso, 2005).


  • Neuron-specific knockdown of Dspastin results in HSP-related phenotypes.
  • Mutant Dspastin behaves as a dominant negative in vivo.
  • Administration of vinblastine attenuates disease-related phenotypes in vivo.

Go to top

Dutta, S., Rieche, F., Eckl, N., Duch, C. and Kretzschmar, D. (2015). Glial expression of Swiss-cheese (SWS), the Drosophila orthologue of Neuropathy Target Esterase, is required for neuronal ensheathment and function. Dis Model Mech [Epub ahead of print]. PubMed ID: 26634819

Swiss-cheese (SWS) and its vertebrate ortholog Neuropathy Target Esterase (NTE) cause progressive neuronal degeneration in Drosophila and mice and a complex syndrome in humans that includes mental retardation, spastic paraplegia, and blindness. SWS and NTE are widely expressed in neurons but can also be found in glia however the function in glia is unknown. This study used a knockdown approach to specifically address SWS function in glia and probe for resulting neuronal dysfunctions. This reveals that loss of SWS in pseudocartridge glia causes the formation of multi-layered glial whorls in the lamina cortex, the first optic neuropil. This phenotype can be rescued by the expression of SWS and NTE suggesting that the glial function is conserved in the vertebrate protein. SWS is also required for the glial wrapping of neurons by ensheathing glia and its loss in glia causes axonal damage. Severe locomotion deficits in glial SWS knockdown flies were detected at 2d and were found to increase further with age. Utilizing the giant fiber system to test for underlying functional neuronal defects, it was found that the response latency to a stimulus is unchanged in knockdown flies compared to controls but the reliability with which the neurons responded to increasing frequencies is reduced. This shows that the loss of SWS in glia impairs neuronal function, thereby playing an important role in the phenotypes described in the sws mutant. It is therefore likely that changes in glia also contribute to the pathology observed in patients that carry mutations in NTE (Dutta, 2015).


  • Loss of glial SWS leads to abnormal glial morphology and death.
  • SWS is required in subperineurial glia.
  • Loss of SWS results in loss of neurite ensheathment by glia.
  • The phospholipase function of SWS plays a crucial role in glia.
  • Loss of glial SWS leads to locomotion deficits.
  • The glial knockdown induces defects in neuronal transmission.

Go to top

O'Sullivan, N.C., Jahn, T.R., Reid, E. and O'Kane, C.J. (2012). Reticulon-like-1, the Drosophila orthologue of the hereditary spastic paraplegia gene reticulon 2, is required for organization of endoplasmic reticulum and of distal motor axons. Hum Mol Genet 21: 3356-3365. PubMed ID: 22543973

Several causative genes for hereditary spastic paraplegia encode proteins with intramembrane hairpin loops that contribute to the curvature of the endoplasmic reticulum (ER), but the relevance of this function to axonal degeneration is not understood. One of these genes is reticulon2. In contrast to mammals, Drosophila has only one widely expressed reticulon orthologue, Rtnl1, and this study used Drosophila to test its importance for ER organization and axonal function. Rtnl1 distribution overlaps with that of the ER, but in contrast to the rough ER, is enriched in axons. Loss of Rtnl1 leads to the expansion of the rough or sheet ER in larval epidermis and elevated levels of ER stress. It also causes abnormalities specifically within distal portions of longer motor axons and in their presynaptic terminals, including disruption of the smooth ER (SER), the microtubule cytoskeleton and mitochondria. In contrast, proximal axon portions appear unaffected. These results provide direct evidence for reticulon function in the organization of the SER in distal longer axons, and support a model in which spastic paraplegia can be caused by impairment of axonal the SER. These data provide a route to further understanding of both the role of the SER in axons and the pathological consequences of the impairment of this compartment (O'Sullivan, 2012).


  • Loss of Rtnl1, the Drosophila orthologue of vertebrate reticulons 1-4, causes age-related locomotor deficits.
  • Rtnl1 is required for normal ER organization and function.
  • Loss of Rtnl1 leads to defects in longer motor axons.
  • Loss of Rtnl1 causes disrupted mitochondrial organization in posterior NMJs.

Go to top


Deshpande, M. and Rodal, A.A. (2016). The crossroads of synaptic growth signaling, membrane traffic and neurological disease: Insights from Drosophila. Traffic 17: 87-101. PubMed ID: 26538429

Go to top

Back to Drosophila as a Model for Human Diseases

Date revised: 12 Feb 2016

Home page: The Interactive Fly © 2015 Thomas Brody, Ph.D.

The Interactive Fly resides on the web server of the Society for Developmental Biology